Health & bio

FDA Fast Track: NextCure's SIM0505 for platinum-resistant ovarian cancer

NextCure announced FDA Fast Track designation for its ADC SIM0505 in platinum-resistant ovarian cancer on April 7. Dose optimization begins Q2 2026.

Primary sources · 1
Oncology News Central
← View the full 2026-04-05 (Sun) issue
What you're reading now arrives in your inbox daily at 21:00 UTC.

Get today's brief every day at 21:00 UTC

7 must-reads · 17 fields · tracked storylines delivered to your inbox daily. Pick only the fields you want; unsubscribe anytime.

Past issues →